Mariner’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.4M | Sell |
697,297
-79,203
| -10% | -$7.59M | 0.07% | 228 |
|
|
2025
Q4 | $74.6M | Buy |
776,500
+37,485
| +5% | +$3.64M | 0.09% | 188 |
|
|
2025
Q3 | $70.4M | Buy |
739,015
+39,591
| +6% | +$3.64M | 0.09% | 179 |
|
|
2025
Q2 | $61M | Buy |
699,424
+28,405
| +4% | +$2.41M | 0.09% | 197 |
|
|
2025
Q1 | $60.3M | Buy |
671,019
+28,469
| +4% | +$2.55M | 0.1% | 181 |
|
|
2024
Q4 | $51.3M | Sell |
642,550
-8,177
| -1% | -$708K | 0.09% | 203 |
|
|
2024
Q3 | $58.6M | Sell |
650,727
-4,188
| -0.6% | -$352K | 0.1% | 184 |
|
|
2024
Q2 | $51.5M | Buy |
654,915
+19,226
| +3% | +$1.58M | 0.1% | 187 |
|
|
2024
Q1 | $55.4M | Buy |
635,689
+576
| +0.1% | +$49.2K | 0.11% | 177 |
|
|
2023
Q4 | $52.3M | Sell |
635,113
-60,485
| -9% | -$4.61M | 0.12% | 161 |
|
|
2023
Q3 | $54.5M | Buy |
695,598
+11,664
| +2% | +$976K | 0.15% | 139 |
|
|
2023
Q2 | $60.3M | Buy |
683,934
+47,965
| +8% | +$4.13M | 0.16% | 127 |
|
|
2023
Q1 | $51.3M | Sell |
635,969
-18,229
| -3% | -$1.49M | 0.15% | 141 |
|
|
2022
Q4 | $50.9M | Buy |
654,198
+18,666
| +3% | +$1.51M | 0.16% | 138 |
|
|
2022
Q3 | $51.3M | Buy |
635,532
+69,012
| +12% | +$6.2M | 0.21% | 117 |
|
|
2022
Q2 | $50.8M | Buy |
566,520
+88,167
| +18% | +$8.93M | 0.21% | 118 |
|
|
2022
Q1 | $53.1M | Buy |
478,353
+62,322
| +15% | +$6.58M | 0.2% | 116 |
|
|
2021
Q4 | $43M | Buy |
416,031
+31,211
| +8% | +$3.61M | 0.18% | 130 |
|
|
2021
Q3 | $48.2M | Buy |
384,820
+19,571
| +5% | +$2.53M | 0.25% | 103 |
|
|
2021
Q2 | $45.3M | Sell |
365,249
-19,094
| -5% | -$2.4M | 0.28% | 100 |
|
|
2021
Q1 | $45.4M | Sell |
384,343
-64,800
| -14% | -$7.59M | 0.32% | 94 |
|
|
2020
Q4 | $52.6M | Buy |
449,143
+49,983
| +13% | +$5.5M | 0.4% | 64 |
|
|
2020
Q3 | $41.5M | Sell |
399,160
-4,493
| -1% | -$451K | 0.39% | 68 |
|
|
2020
Q2 | $37M | Buy |
403,653
+4,989
| +1% | +$478K | 0.37% | 75 |
|
|
2020
Q1 | $36M | Buy |
398,664
+6,858
| +2% | +$730K | 0.45% | 59 |
|
|
2019
Q4 | $44.5M | Buy |
391,806
+24,260
| +7% | +$2.66M | 0.46% | 60 |
|
|
2019
Q3 | $39.9M | Buy |
367,546
+2,718
| +0.7% | +$284K | 0.48% | 57 |
|
|
2019
Q2 | $35.5M | Sell |
364,828
-12,607
| -3% | -$1.15M | 0.42% | 68 |
|
|
2019
Q1 | $26.5M | Buy |
377,435
+115,074
| +44% | +$10.3M | 0.38% | 71 |
|
|
2018
Q4 | $23.9M | Buy |
262,361
+137,863
| +111% | +$12.9M | 0.42% | 66 |
|
|
2018
Q3 | $12.2M | Buy |
124,498
+44,522
| +56% | +$4.12M | 0.31% | 75 |
|
|
2018
Q2 | $6.85M | Buy |
79,976
+19,358
| +32% | +$1.62M | 0.19% | 118 |
|
|
2018
Q1 | $4.86M | Buy |
60,618
+35,839
| +145% | +$2.96M | 0.17% | 114 |
|
|
2017
Q4 | $2M | Buy |
24,779
+9,958
| +67% | +$798K | 0.08% | 208 |
|
|
2017
Q3 | $1.15M | Sell |
14,821
-2,418
| -14% | -$201K | 0.05% | 242 |
|
|
2017
Q2 | $1.53M | Buy |
17,239
+1,463
| +9% | +$123K | 0.07% | 202 |
|
|
2017
Q1 | $1.27M | Sell |
15,776
-5,233
| -25% | -$409K | 0.06% | 244 |
|
|
2016
Q4 | $1.5M | Sell |
21,009
-2,018
| -9% | -$159K | 0.07% | 223 |
|
|
2016
Q3 | $1.99M | Buy |
23,027
+10,142
| +79% | +$884K | 0.1% | 183 |
|
|
2016
Q2 | $1.12M | Buy |
12,885
+1,676
| +15% | +$136K | 0.06% | 234 |
|
|
2016
Q1 | $841K | Buy |
11,209
+528
| +5% | +$39.8K | 0.05% | 260 |
|
|
2015
Q4 | $822K | Sell |
10,681
-142,930
| -93% | -$10.8M | 0.05% | 230 |
|
|
2015
Q3 | $10.3M | Buy |
153,611
+130,889
| +576% | +$9.64M | 0.46% | 66 |
|
|
2015
Q2 | $1.68M | Buy |
+22,722
| New | +$1.74M | 0.08% | 192 |
|
Other funds holding MDT
VCM
VPM
Mariner's MDT Position: Q1 2026 in Review
Mariner reduced its Medtronic (MDT) stake by 10% in Q1 2026, selling an estimated $7.59M and leaving 697,297 shares worth $60.4M. The position accounts for 0.07% of the portfolio, ranked #228.
Mariner first reported a position in MDT in Q2 2015 and has held it in 44 quarters since. The position peaked at $74.6M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Mariner held 697,297 shares of Medtronic worth $60.4M as of Q1 2026.
- Mariner sold 79,203 Medtronic shares in Q1 2026, an estimated $7.59M.
- Medtronic made up 0.07% of Mariner's portfolio in Q1 2026, its #228 holding.
- Mariner first reported a position in Medtronic in Q2 2015 and has held it in 44 quarters since.
- Mariner's Medtronic position peaked at $74.6M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.